Nutrient Regulation by Continuous Feeding Removes Limitations on Cell Yield in the Large-Scale Expansion of Mammalian Cell Spheroids

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Weegman, Bradley P ^a   Nash, Peter ^a   Carlson, Alexandra L ^a   Voltzke, Kristin J ^a   Geng, Zhaohui ^a   Jahani, Marjan ^a   Becker, Benjamin B ^a   Papas, Klearchos K ^a,b   Firpo, Meri T ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ANIMAL CELL; ARTICLE; BIOREACTOR; CELL AGGREGATION; CELL CULTURE; CELL EXPANSION; CELL FUNCTION; CELL GROWTH; CELL VIABILITY; CELL YIELD; CONTINUOUS FEEDING SYSTEM; CONTROLLED STUDY; CULTURE TECHNIQUE; GROWTH RATE; INSULINOMA; MAMMAL CELL; NONHUMAN; NUTRIENT; NUTRIENT REGULATION; REPRODUCIBILITY; SPHEROID CELL; TUMOR CELL;

ANIMALS; BATCH CELL CULTURE TECHNIQUES; BIOREACTORS; CELL LINE; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; CULTURE MEDIA; GLUCOSE; HUMANS; SPHEROIDS, CELLULAR; TIME FACTORS;

EID: 84885768810     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076611     Document Type: Article

References (48)

1. Reuveny S, Velez D, Macmillan JD, Miller L, (1986) Factors affecting cell growth and monoclonal antibody production in stirred reactors. J Immunol Methods 86: 53-59.
2. Tarleton RL, Beyer AM, (1991) Medium-scale production and purification of monoclonal antibodies in protein-free medium. Biotechniques 11: 590-593.
3. Hay RJ, (1991) Operator-induced contamination in cell culture systems. Dev Biol Stand 75: 193-204.
4. Dazey B, Duchez P, Letellier C, Vezon G, Ivanovic Z, (2005) Cord blood processing by using a standard manual technique and automated closed system "Sepax" (Kit CS-530). Stem Cells Dev 14: 6-10.
5. Gastens MH, Goltry K, Prohaska W, Tschöpe D, Stratmann B, et al. (2007) Good Manufacturing Practice-Compliant Expansion of Marrow-Derived Stem and Progenitor Cells for Cell Therapy. Cell Transplant 16: 685-696.
6. Naing MW, Williams DJ, (2011) Three-dimensional culture and bioreactors for cellular therapies. Cytotherapy 13: 391-399.
7. Stacey GN, Cenic A, (2011) Cell culture contamination. Methods Mol Biol 731: 79-91.
8. Sharma S, Raju R, Sui S, Hu W, (2011) Stem cell culture engineering - process scale up and beyond. Biotechnol J 6: 1317-1329.
9. Zur Nieden NI, Cormier JT, Rancourt DE, Kallos MS, (2007) Embryonic stem cells remain highly pluripotent following long term expansion as aggregates in suspension bioreactors. J Biotechnol 129: 421-432.
10. Kehoe DE, Jing D, Lock LT, Tzanakakis ES, (2010) Scalable Stirred-Suspension Bioreactor Culture. Tissue Eng Part A 16: 405-421.
11. Krawetz R, Taiani JT, Liu S, Meng G, Li X, et al. (2010) Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. Tissue Eng Part C Methods 16: 573-582.
12. Shafa M, Sjonnesen K, Yamashita A, Liu S, Michalak M, et al. (2011) Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors. J Tissue Eng Regen Med 6: 4-7.
13. Oh SKW, Chen AK, Mok Y, Chen X, Lim UM, et al. (2010) Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res 16: 219-230.
14. Olmer R, Lange A, Selzer S, Kasper C, Haverich A, et al. (2012) Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng Part C Methods. 18: 772-784.
15. Baptista RP, Fluri DA, Zandstra PW, (2013) High density continuous production of murine pluripotent cells in an acoustic perfused bioreactor at different oxygen concentrations. Biotechnol Bioeng 110: 648-655.
16. Papas KK (1992) Characterization of the metabolic and secretory behavior of suspended free and entrapped ART-20 spheroids in fed-batch and perfusion cultures. MS thesis, Georgia Institute of Technology, Atlanta GA.
17. Papas KK, Constantinidis I, Sambanis A, (1993) Cultivation of recombinant, insulin-secreting AtT-20 cells as free and entrapped spheroids. Cytotechnology. 13: 1-12.
18. Sambanis A, Papas KK, Flanders PC, Long RC, Kang H, et al. (1994) Towards the development of a bioartificial pancreas: immunoisolation and NMR monitoring of mouse insulinomas. Cytotechnology 15: 351-363.
19. Papas KK, Long RC, Constantinidis I, Sambanis A, (1997) Role of ATP and Pi in the mechanism of insulin secretion in the mouse insulinoma βTC3 cell line. Biochem J 814: 807-814.
20. Papas KK, Long Jr RC, Sambanis A, Constantinidis I, (1999a) Development of a Bioartificial Pancreas: I. Long-Term Propagation and Basal and Induced Secretion from Entrapped βTC3 Cell Cultures. Biotechnol Bioeng 66(4): 219-230.
21. Papas KK, Long RC, Sambanis A, Constantinidis I, (1999b) Development of a Bioartificial Pancreas: II. Effects of Oxygen on Long-Term Entrapped βTC3 Cell Cultures. Biotechnol Bioeng 66(4): 231-237.
22. Hu WS, (1994) Cell culture process monitoring and control- a key to process optimization. Cytotechnology 14: 155-156.
23. Knaack D, Fiore DM, Surana M, Leiser M, Laurance M, et al. (1994) Clonal insulinoma cell line that stably maintains correct glucose responsiveness. Diabetes 43: 1413-1417.
24. Poitout V, Stout LE, Armstrong MB, Walseth TF, Sorenson RL, et al. (1995) Morphological and functional characterization of beta TC-6 cells-an insulin-secreting cell line derived from transgenic mice. Diabetes 44: 306-313.
25. Poitout V, Olson LK, Robertson RP, (1996) Insulin-secreting cell lines: classification, characteristics and potential applications. Diabetes Metab 22: 7-14.
26. Suzuki R, Okada N, Miyamoto H, Yoshioka T, Sakamoto K, et al. (2002) Cyotomedical therapy for insulinopenic diabetes using microencapsulated pancreatic beta cell lines. Life Sci 71: 1717-1729.
27. Skelin M, Rupnik M, (2010) Pancreatic Beta Cell Lines and their Applications in Diabetes Mellitus Research. ALTEX 27: 105-113.
28. Masters JR, Stacey GN, (2007) Changing medium and passaging cell lines. Nat Protoc 2: 2276-2284.
29. Murdoch TB, McGhee-Wilson D, Shapiro AM, Lakey JR, (2004) Methods of human islet culture for transplantation. Cell Transplant 13: 605-617.
30. Woodside SM, Bowen BD, Piret JM, (1998) Mammalian cell retention devices for stirred perfusion bioreactors. Cytotechnology 28: 163-175.
31. Liu H, Liu XM, Li SC, Wu BC, Ye LL, et al. (2009) A high-yield and scaleable adenovirus vector production process based on high density perfusion culture of HEK 293 cells as suspended aggregates, J Biosci Bioeng. 107: 524-529.
32. Zhi ZL, Liu B, Jones PM, Pickup JC, (2010) Polysaccharide multilayer nanoencapsulation of insulin-producing beta-cells grown as pseudoislets for potential cellular delivery of insulin. Biomacromolecules 11: 610-616.
33. Lock LT, Laychock SG, Tzanakakis ES, (2011) Pseudoislets in stirred-suspension culture exhibit enhanced cell survival, propagation and insulin secretion. J Biotechnol 151: 278-286.
34. Serra M, Brito C, Sousa MFQ, Jensen J, Tostões R, et al. (2010) Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J Biotechnol 148: 208-215.
35. Gálvez J, Lecina M, Solà C, Cairó JJ, Gòdia F, (2012) Optimization of HEK-293S cell cultures for the production of adenoviral vectors in bioreactors using on-line OUR measurements. J Biotechnol 157: 214-222.
36. Trabelsi K, Majoul S, Rourou S, Kallel H, (2012) Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor. Appl Microbiol Biotechnol 93: 1031-1040.
37. Marchenko S, Flanagan L (2007) Counting human neural stem cells. J Vis Exp 262.
38. Campos C, (2012) Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae. Postgrad Med 124: 90-97.
39. Klüh U, Liu Z, Cho B (2006) Continuous glucose monitoring in normal mice and mice with prediabetes and diabetes. Diabetes Technol Ther, 8(3), 402-412. Retrieved from http://online.liebertpub.com/doi/abs/10.1089/dia.2006.8.402.
40. Eve DJ, Fillmore R, Borlongan CV, Sanberg PR, (2010) Stem cells have the potential to rejuvenate regenerative medicine research. Med Sci Monit 16: 197-217.
41. Hsiao LC, Carr C, Chang KC, Lin SZ, Clarke K (2013) Stem Cell-based Therapy for Ischemic Heart Disease. Cell Transplant. In press.
42. Oldershaw RA, (2012) Cell sources for the regeneration of articular cartilage: the past, the horizon and the future. Int J Exp Pathol 93: 389-400.
43. De Coppi P, (2013) Regenerative medicine for congenital malformations. J Pediatr Surg 48: 273-280.
44. Tziampazis E, Sambanis A, (1994) Modeling of cell culture processes. Cytotechnology 14: 191-204.
45. Sidoli FR, Mantalaris A, Asprey SP, (2004) Modelling of Mammalian cells and cell culture processes. Cytotechnology 44: 27-46.
46. Yim R, (2005) Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside. Transfusion 45: 144S-58S.
47. Fink DW, (2009) FDA regulation of stem cell-based products. Science. 324: 1662-1663.
48. Moos M (2008) Stem-cell-derived products: an FDA update. Trends Pharmacol Sci 591-3.